Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

ABSTRACTIVE HEALTH, INC.

UEI: F96BEK5HFDN3CAGE: 9H0Y3

ABSTRACTIVE HEALTH, INC. is a federal contractor, registered under UEI F96BEK5HFDN3 and CAGE code 9H0Y3. It has been awarded $1,544,991 across 2 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include National Science Foundation.

Contact Information

Registration and classification details

Registration

UEI Code

F96BEK5HFDN3

CAGE Code

9H0Y3

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

2X

NAICS Codes

541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

ABSTRACTIVE HEALTH, INC. specializes in advanced health data analytics and research support services, leveraging computational methods to extract actionable insights from complex biomedical and clinical datasets. Their core capabilities include natural language processing of unstructured health reco...

ABSTRACTIVE HEALTH, INC. specializes in advanced health data analytics and research support services, leveraging computational methods to extract actionable insights from complex biomedical and clinical datasets. Their core capabilities include natural language processing of unstructured health records, statistical modeling of population health trends, and the development of algorithmic tools to support evidence-based decision-making in public health and clinical research. The company applies expertise in data governance, HIPAA-compliant data pipelines, and interoperability standards such as HL7 and FHIR to enable secure, scalable analysis of health information systems. Their technical differentiation lies in the integration of machine learning frameworks with domain-specific clinical ontologies, allowing for nuanced interpretation of real-world health data without compromising privacy or regulatory compliance. No agency relationships can be inferred from available award data, and no recent contract awards are documented to illustrate specific federal engagements. As a result, patterns of agency collaboration or mission-specific support cannot be determined from the provided information. The primary NAICS code 541715 indicates a focus on research and development in the life sciences, specifically in the realm of scientific and technical consulting services related to health and biomedical innovation. In practice, this translates to supporting government and academic stakeholders with analytical infrastructure, data synthesis, and translational research tools rather than direct service delivery or clinical operations. ABSTRACTIVE HEALTH, INC. is structured as a small business (2L) based in New York, NY, with no government certifications disclosed. The company operates as a specialized research services provider, positioned in the federal health analytics market as a technical partner for data-driven initiatives, though its current market footprint cannot be assessed due to insufficient award history.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
National Science Foundation$1.5M100%
Awards by NAICS
- Unknown NAICS$1.5M100%
Awards by Agency Over Time
Export
Awards by Place of Performance

Open opportunities in ABSTRACTIVE HEALTH, INC.'s top NAICS codes and agencies

NAICS: 221111
SBIR / STTR
Energy Technologies
Solicitation # EN
The Energy Technologies solicitation seeks innovative proposals across a broad spectrum of energy generation, storage, and conversion systems with a focus on mobile and off-grid applications. It welcomes ideas that offer compelling advantages over existing solutions, particularly in emerging areas such as carbon conversion, disruptive improvements to conventional energy resources like natural gas extraction, and nature-inspired processes aimed at reducing carbon and resource intensity throughout the energy lifecycle. Proposals that integrate data and computational technologies with energy systems are strongly encouraged, especially where the synergy between digital innovation and energy application is central to the proposed solution. The scope spans from microscopic energy storage for wearable devices to large-scale power plant technologies, emphasizing technological scalability and sustainability. This is a small business set-aside opportunity under the SBIR/STTR mandate, restricted to organizations with fewer than 500 employees, and is classified under NAICS code 221111 for electric power generation. Managed by the National Science Foundation, the solicitation was posted on May 22, 2026, with a submission deadline of July 7, 2027. While no specific physical place of performance is required, applicants must demonstrate the potential for practical implementation and impact in the U.S. energy landscape. The initiative prioritizes breakthroughs that advance clean, efficient, and resilient energy technologies while fostering innovation within small businesses to address critical national energy challenges.
National Science Foundation

POSTED

3 months ago

DEADLINE

in 11 months
View Details
NAICS: 541714
SBIR / STTR
Pharmaceutical Technologies
Solicitation # PT
The Pharmaceutical Technologies solicitation under the NSF SBIR/STTR program supports innovation in drug discovery and manufacturing processes that enhance the selection, quality, or cost-effectiveness of pharmaceutical and biologic therapies. It focuses on advanced technologies such as novel formulations, scalable production platforms, and process innovations that enable more efficient and reliable development of therapeutics, while explicitly excluding support for clinical trials, pre-clinical or clinical-stage drug candidates, medical devices, schedule I substances, and work driven solely by regulatory compliance. The program continues to encourage breakthroughs in drug discovery and manufacturing but no longer funds the development of specific therapeutic molecules. This solicitation is a total small business set-aside under the SBA mandate, restricted to businesses with fewer than 500 employees, and is categorized under NAICS code 541714 for research and development in the physical, engineering, and life sciences. Administered by the National Science Foundation, the opportunity was posted on May 22, 2026, with a response deadline of July 7, 2027. Proposals must align with the program’s mission to advance foundational technologies that improve pharmaceutical outcomes without engaging in direct therapeutic development or clinical evaluation, ensuring that funds are directed toward enabling platforms and methodologies with broad application potential.
National Science Foundation

POSTED

3 months ago

DEADLINE

in 11 months
View Details